Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.

Cancer - 1 Sept 2008

Kharfan-Dabaja Mohamed A, Chavez Julio C, Khorfan Khadija A, Pinilla-Ibarz Javier

Abstract excerpt

The past 2 decades have brought major advances to clinicians' understanding of the complexities of chronic lymphocytic leukemia (CLL). Novel biologic and genetic markers are providing tools for more accurate prediction of responses, disease progression, and survival of patients across different stages of CLL. Several multivariate analyses have confirmed unmutated IgVH to be an independent adverse prognostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoglobulin Heavy Chains

Share to Immunoglobulin Variable Region

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 18618518
DOI: 10.1002/cncr.23671

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.PMID 18618518Read ↗

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatmentSemantic proximity Read ↗

Chronic lymphocytic leukemia with mutated IgVH1-69 usage: a distinct CLL subgroup with more indolent behavior?Semantic proximity Read ↗

Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.Semantic proximity Read ↗

Genomic Features: Impact on Pathogenesis and Treatment of Chronic Lymphocytic Leukemia.Semantic proximity Read ↗

Molecular map of chronic lymphocytic leukemia and its impact on outcome.Semantic proximity Read ↗

IgVH mutations in patients with chronic lymphocytic leukemia.Semantic proximity Read ↗

Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemiaSemantic proximity Read ↗

MYD88 mutations predict unfavorable prognosis in Chronic Lymphocytic Leukemia patients with mutated IGHV geneSemantic proximity Read ↗

Prognostic factors and risk stratification in chronic lymphocytic leukemia.Semantic proximity Read ↗

IGHV mutational status testing in chronic lymphocytic leukemia.Semantic proximity Read ↗

Implications of new prognostic markers in chronic lymphocytic leukemia.Semantic proximity Read ↗

Molecular profiling in CLL.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.